Abstract:IntroductionEsophageal cancer (EC) is the eighth most common cancer and the sixth most common cause of cancer death worldwide.Esophageal squamous cell carcinoma (ESCC) and adenocarcinoma (EAC) are two major histopathological type of esophageal cancer.The incidence of EC was increased in the past 3 decades.Five-year survival of advanced cancer is still very poor, even though improved surgical techniques and adjuvant chemoradiation therapy.It is very important to understand esophageal cancer biology. Genetic changes in esophageal cancerGenetic change is one of the major events in transforming normal esophageal epithelia to malignant cells.Mutations and genetic polymorphisms in coding gene sequences may cause functional alteration of genes.Functional mutation and single nucleotide polymorphism (SNP) (eg.p53,SULT1A1, CYP3A5, ALDH2, ADH1B1 and ECRG1) is related to susceptibility of esophageal cancer. Effects of mutations and SNPs in esophageal cancerP53 is involved in multiple cellular pathways including apoptosis, transcriptional regulation, and cell cycle control.Alterations in p53 have been reported to occur at an early stage of EC.P53 mutation was observed in exon 5 and accounted for about 77% of ESCC patients (Hu, Huang et al., 2001).Fanconi gene family is another interesting example.The risk of ESCC is associated with both heterozygous and homozygous mutations in several Fanconi anemia-predisposing genes, such as heterozygous insertion/deletion mutations in FANCD2 (p.Val1233-del), FANCE (p.Val311SerfsX2) and FANCL (p.Thr367AsnfsX13) (Akbari et al., 2011).SNPs in p53 pathway also play important roles in EC tumorigenesis.SNP in p53 gene (Arg72Pro) decreased apoptosis and was associated with increased risk, earlier age of onset, reduced response to chemotherapy and early recurrence in esophageal cancers (Pietsch et al., 2006).T309G is located in the promoter region of MDM2, which is the regulator of p53 pathway.Transcription factor may easily bind to the G variant of MDM2, increase MDM2 www.intechopen.comEsophageal Cancer -Cell and Molecular Biology, Biomarkers, Nutrition and Treatment 2 expression and reduce apoptosis in response to DNA damage (Bond et al., 2004).MDM2 T309G G/G was associated with an increased risk of death in ESCC (Cescon et al., 2009).SNPs in key genes are associated with EC, such as genes involved in nucleotide excision repair (NER) and base excision repair (BER) pathways.The increasing number of variant alleles in SNPs of NER showed a significant trend to EAC, including XPD Lys751Gln, ERCC1 8092 C/A and ERCC1 118C/T (Tse et al., 2008).Esophageal cancer related gene 1 (ECRG1) is reported as a novel tumor suppressor.ECRG1 is normally expressed in esophagus, but reduced in ESCC.ECRG1 (Arg290Gln) was identified as the susceptible SNP of ESCC (Li et al., 2006).It has been found that the increased risk of ESCC relates to combined SULT1A12*2 genotype and CYP3A5 heterozygous genotypes, especially in tobacco smokers (Dandara et al., 2006).SNP of ATP-binding cassette sub-family B (MDR/TAP) member 1 gene (ABCB1) was reported to be associated with lymph node and distant metastases in EC (Narumiya et al., 2011).SNP also impacted disease-free survival (DFS) of ECs.The MDM2 T/G and CDH1 GA/GA genotype confer risk of death in EAC patients (Boonstra et al., 2011).Vascular endothelial growth factor (VEGF) 936C/T is associated with an improved overall survival compared with wild type genotype in EC (Bradbury et al., 2009). Effects of chromosomal abnormalities in esophageal cancerGenomic alterations, such as amplification, deletion, translocation and loss of heterozygosity (LOH) play an important role in initiation and progression of cancer.Recently a panel of chromosome instability biomarkers, including LOH and DNA content, has been reported to identify patients at high and low risk of progression from Barrett's esophagus (BE) to EAC (Paulson et al., 2009).

Cyclin D1 Guanine/Adenine 870 Polymorphism with Altered Protein Expression is Associated with Genomic Instability and Aggressive Clinical Biology of Esophageal Adenocarcinoma

Cyclin D1 Polymorphism, Biochemoprevention and Risk of Upper Aero-Digestive Tract Cancer Development.

Molecular Biology Character of Esophageal Cancer

Data from Genome-Wide Catalogue of Chromosomal Aberrations in Barrett's Esophagus and Esophageal Adenocarcinoma: A High-Density Single Nucleotide Polymorphism Array Analysis

Lack of association between CCND1 G870A polymorphism and risk of esophageal squamous cell carcinoma.

Elevated APE1 Dysregulates Homologous Recombination and Cell Cycle Driving Genomic Evolution, Tumorigenesis, and Chemoresistance in Esophageal Adenocarcinoma

Association of Cyclin D1 Genotype with Breast Cancer Risk and Survival

Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.

Polymorphism in Epidermal Growth Factor Receptor Intron 1 Predicts Prognosis of Patients with Esophageal Cancer after Chemoradiation and Surgery

GG Genotype of Cyclin D1 G870A Polymorphism is Associated with Non-Cardiac Gastric Cancer in a High-Risk Region of China.

Integrated genomics and comprehensive validation reveal drivers of genomic evolution in esophageal adenocarcinoma

Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis.

Expression and Prognostic Value of Cell-Cycle-associated Genes in Gastric Adenocarcinoma

Abstract C03: A Comprehensive Study of Genomic Alterations Reveals Deregulation of the Cell Cycle in Most Esophageal Squamous Cell Carcinomas

Drug-induced Expression of EpCAM Contributes to Therapy Resistance in Esophageal Adenocarcinoma.

CCND1G870A Polymorphism with Altered Cyclin D1 Transcripts Expression is Associated with the Risk of Glioma in a Chinese Population

Abstract 1349: Genetic Variants in DNA Repair Pathway Genes Are Associated with the Risk of Esophageal Adenocarcinoma.

Influence of cyclin D1 splicing variants expression on breast cancer chemoresistance via CDK4/CyclinD1-pRB-E2F1 pathway

Cyclin D1 G870A Polymorphism and Lung Cancer Risk: a Meta-Analysis

Distinct Landscapes of Genetic and Epigenetic Alterations of E2F Family Genes Between Esophageal Squamous Cell Carcinoma and Esophageal Adenocarcinoma

Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions.